Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Prostate Cancer: A Unique and Common Cancer Affecting Men 

    Most cancers affect everyone, regardless of sex, race, age, and other factors. Prostate cancer, however, only affects…
    October 2, 2023| Max Mallet
  • 2021 William B. Coley Award Recipients Drs. Katalin Karikó and Drew Weissman Receive the 2023 Nobel Prize in Physiology or Medicine 

    On October 2 the Nobel Assembly at Karolinska Institute in Stockholm, Sweden, announced that the 2023 Nobel…
    October 2, 2023| Max Mallet
  • CRI Received a 100% ‘Four-Star Charity’ Rating – Here’s Why That Matters 

    When people seek out nonprofits with missions that align with their values, it can be initially challenging…
    September 18, 2023| Max Mallet
  • Drs. Carl June and Michel Sadelain to Receive 2024 Breakthrough Prize in Life Sciences

    CRI Scientific Advisory Council member Carl June, MD (University of Pennsylvania) and CRI Clinical Accelerator Advisor Michel…
    September 14, 2023| Max Mallet
  • Cancer Cabinet Declares Updates to President Biden’s Cancer Moonshot Initiative 

    U.S. President Joe Biden’s administration is following through on last year’s commitment to reignite the White House…
    September 13, 2023| Max Mallet
  • Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field 

    iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill…
    September 12, 2023| CRI Staff
  • Join #TeamCRI and Plan Your Own Tailgate for a Purpose

    The Cancer Research Institute (CRI) now has a new way to create a world immune to cancer,…
    August 30, 2023| CRI Staff
  • CRI’s Dr. Jill O’Donnell-Tormey Explains Five Things You Need to Know About Cancer Vaccines

    Vaccines had been effective at preventing viral and bacterial-borne viruses for two hundred years before the first…
    August 28, 2023| CRI Staff
  • Recent Innovations and Challenges in Fighting Blood Cancers

    The term “blood cancer” encompasses several types of cancer, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS),…
    August 21, 2023| Max Mallet
Previous Page
1 … 20 21 22 23 24 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal